[Glycolytic enzyme defects and neurodegeneration]
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1999
Summary
Triosephosphate isomerase (TPI) deficiency can cause neurodegeneration due to altered membrane properties and reduced plasmalogen levels, increasing oxidative stress. These lipid changes impact cellular functions and contribute to neuronal death pathways.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Investigating neurodegeneration in Triosephosphate Isomerase (TPI) deficiency, focusing on a patient with severe neurological symptoms despite a sibling with identical genetic defect but no symptoms.
- Examining the role of plasmalogens (PLs) and their impact on cell membrane biophysical properties in neurodegenerative processes.
Observation:
- Reduced levels of major phospholipid subclasses and particularly phosphatidylethanolamine (PE) plasmalogens were observed.
- Decreased levels of glutathione (GSH) and alpha-tocopherol indicate chronic oxidative stress in the affected individual.
- Altered membrane fluidity and impaired protection against oxidative stress were noted.
Findings:
- The study proposes that altered protein-product structures in TPI deficiency affect Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) binding.
- Changes in phospholipid composition and membrane biophysical properties critically influence protein-protein interactions and enzyme activity.
- Plasmalogen depletion exacerbates oxidative stress, worsening neurodegeneration and potentially leading to apoptosis via calcium homeostasis disruption.
Implications:
- Lipids are not inert but actively participate in cellular functions and disease pathogenesis.
- Understanding the interplay between genetic defects, lipid alterations, and membrane biophysics is crucial for unraveling neurodegeneration.
- This research highlights the need for integrated studies on genetic and lipid-based mechanisms in neurodegenerative diseases.
Related Concept Videos
00:56What is Glycolysis?
Overview
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...